John W. A. Findlay
Papers
1
Total Citations
39
H-Index
1
About
John W. A. Findlay is a leading authority in bioanalytical chemistry, with a career-long focus on the development, validation, and implementation of ligand-binding assays (LBAs) for drug development. His seminal work, including the highly cited 2010 volume *Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena*, serves as a definitive guide for the field. Findlay’s major contributions center on establishing rigorous bioanalytical standards for macromolecule therapeutics, bridging the gap between early discovery and clinical application. His historical perspective, co-authored with Masood N. Khan, provides critical context for the evolution of LBAs, highlighting their advantages—such as high sensitivity and specificity—over traditional small-molecule methods. With over 39 citations on this key work alone, Findlay’s impact is evident in the widespread adoption of his validation frameworks by pharmaceutical and regulatory bodies. His efforts have been instrumental in shaping how modern biologics are quantified in complex biological matrices, ensuring safety and efficacy in drug development. For students and researchers, Findlay’s legacy offers a masterclass in translating analytical science into tangible therapeutic advances.
Research Focus
Key Achievements
Top Papers
- 1